Jonathan M. Pitt

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Marie Vétizou, Jonathan M. Pitt, Romain Daillère et al. · Science · 2015 · 3.3K citations · Full text

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Benjamin Besse, Mélinda Charrier, Valérie Lapierre et al. · OncoImmunology · 2015 · 754 citations · Full text

Immunology, Immunotherapeutics, Immunotherapy +20

Enhanced protection to <i>Mycobacterium tuberculosis</i> infection in IL‐10‐deficient mice is accompanied by early and enhanced Th1 responses in the lung

Paul S. Redford, André Boonstra, Simon Read et al. · European Journal of Immunology · 2010 · 229 citations · Full text

Inflammatory Lung Disease, Microbial Pathogens, Lung Inflammation +17

Blockade of IL-10 Signaling during Bacillus Calmette-Guérin Vaccination Enhances and Sustains Th1, Th17, and Innate Lymphoid IFN-γ and IL-17 Responses and Increases Protection to <i>Mycobacterium tuberculosis</i> Infection

Jonathan M. Pitt, Evangelos Stavropoulos, Paul S. Redford et al. · The Journal of Immunology · 2012 · 168 citations · Full text

Bcg Vaccination, Microbial Pathogens, Il-17 Responses +25

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

Laetitia Fend, Takahiro Yamazaki, Christelle Remy et al. · Cancer Research · 2017 · 124 citations